IDEAS home Printed from https://ideas.repec.org/p/cdl/itsrrp/qt8fk9x81v.html
   My bibliography  Save this paper

2022 SafeTREC Traffic Safety Fact Sheet: Drug-Involved Driving

Author

Listed:
  • Chen, Katherine L.
  • Tsai, Bor-Wen
  • Fortin, Garrett
  • Cooper, Jill F.

Abstract

The use of cannabis, prescription drugs, and other drugs are increasingly prominent on roadways in the United States,where 25.3 percent of the nation’s 38,824 fatalities in 2020 were related to drug-involved driving. Driving can beimpaired by a variety of legal and illegal drugs, substances, and medications. The effect of specific drugs on behaviorand driving skills vary considerably depending on how they act in the brain and are metabolized. They can slow reactiontime, decrease coordination, increase aggressive and reckless driving, impair cognitive function, or cause drowsiness.All of these effects can contribute to crash risk.Studies suggest that poly-drug use or combining alcohol and drugs can inflate the level of driver impairment and crashrisk. There is variation across jurisdictions in the frequency of testing suspected impaired drivers for drugs, consistencyin laboratory drug testing practices, and capacity of law enforcement personnel. Despite challenges in identifyingcausality and impairment, there is general consensus that many drugs impair driving. Preliminary data from an ongoingNHTSA study of alcohol and drug prevalence during the COVID-19 emergency found some significant increases in theprevalence of drugs detected in blood among fatally and seriously injured drivers, motorcyclists, and pedestrians whencomparing the last quarter of 2019 and the first quarter of 2020 to the second, third, or fourth quarters of 2020. As ofFebruary 2022, nearly three-quarters of states, including California, have legalized medical-use of cannabis productsand over one-third allow recreational cannabis, increasing concerns about traffic safety. According to the NationalInstitute on Drug Abuse, aside from alcohol, cannabis is the most frequently detected drug in drivers who are in crashes.Analyses from FARS presented in the drug-impaired program area include fatalities in crashes that involved a driverwho tested positive for a drug that could cause impairment. Analyses from SWITRS presented in this program area referto drug-involvement and include fatal and serious injuries where law enforcement reported the driver to be under theinfluence of drugs. Crashes in the program area are defined as where one or more drivers tested positive for a drug thatcould cause impairment or was reported as driving under the influence of drugs, depending on which data set is used.

Suggested Citation

  • Chen, Katherine L. & Tsai, Bor-Wen & Fortin, Garrett & Cooper, Jill F., 2022. "2022 SafeTREC Traffic Safety Fact Sheet: Drug-Involved Driving," Institute of Transportation Studies, Research Reports, Working Papers, Proceedings qt8fk9x81v, Institute of Transportation Studies, UC Berkeley.
  • Handle: RePEc:cdl:itsrrp:qt8fk9x81v
    as

    Download full text from publisher

    File URL: https://www.escholarship.org/uc/item/8fk9x81v.pdf;origin=repeccitec
    Download Restriction: no
    ---><---

    More about this item

    Keywords

    Social and Behavioral Sciences;

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:cdl:itsrrp:qt8fk9x81v. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Lisa Schiff (email available below). General contact details of provider: https://edirc.repec.org/data/itucbus.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.